Director Jason Haas sold shares of Ligand Pharmaceuticals on September 13, 2026, which traded on the Nasdaq.
1 report, 1 independent
Updated Sep 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Director Jason Haas sold shares of Ligand Pharmaceuticals on September 13, 2026, which traded on the Nasdaq.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jason Haas
college basketball player (2003–2006) Stanford
Nothing else this week.
-
Ligand Pharmaceuticals
biopharmaceutical company based out of La Jolla, California